nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—amyotrophic lateral sclerosis	0.716	1	CbGaD
Risedronate—FDPS—jaw skeleton—amyotrophic lateral sclerosis	0.0295	0.483	CbGeAlD
Risedronate—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0572	CcSEcCtD
Risedronate—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.00872	0.0391	CcSEcCtD
Risedronate—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00664	0.0298	CcSEcCtD
Risedronate—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00654	0.0293	CcSEcCtD
Risedronate—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00608	0.0995	CbGeAlD
Risedronate—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00536	0.024	CcSEcCtD
Risedronate—PTGS2—appendage—amyotrophic lateral sclerosis	0.00522	0.0854	CbGeAlD
Risedronate—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00512	0.023	CcSEcCtD
Risedronate—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0222	CcSEcCtD
Risedronate—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0215	CcSEcCtD
Risedronate—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0209	CcSEcCtD
Risedronate—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0201	CcSEcCtD
Risedronate—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0181	CcSEcCtD
Risedronate—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00387	0.0174	CcSEcCtD
Risedronate—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0169	CcSEcCtD
Risedronate—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0158	CcSEcCtD
Risedronate—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00345	0.0155	CcSEcCtD
Risedronate—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0154	CcSEcCtD
Risedronate—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0153	CcSEcCtD
Risedronate—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0152	CcSEcCtD
Risedronate—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0148	CcSEcCtD
Risedronate—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0148	CcSEcCtD
Risedronate—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0147	CcSEcCtD
Risedronate—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00315	0.0141	CcSEcCtD
Risedronate—FDPS—medulla oblongata—amyotrophic lateral sclerosis	0.00289	0.0473	CbGeAlD
Risedronate—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0128	CcSEcCtD
Risedronate—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00282	0.0126	CcSEcCtD
Risedronate—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00282	0.0126	CcSEcCtD
Risedronate—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0122	CcSEcCtD
Risedronate—FDPS—spinal cord—amyotrophic lateral sclerosis	0.00258	0.0421	CbGeAlD
Risedronate—Injury—Riluzole—amyotrophic lateral sclerosis	0.00246	0.011	CcSEcCtD
Risedronate—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0104	CcSEcCtD
Risedronate—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0101	CcSEcCtD
Risedronate—FDPS—nervous system—amyotrophic lateral sclerosis	0.00217	0.0355	CbGeAlD
Risedronate—FDPS—central nervous system—amyotrophic lateral sclerosis	0.00209	0.0342	CbGeAlD
Risedronate—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00936	CcSEcCtD
Risedronate—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00916	CcSEcCtD
Risedronate—FDPS—cerebellum—amyotrophic lateral sclerosis	0.00204	0.0334	CbGeAlD
Risedronate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.002	0.00897	CcSEcCtD
Risedronate—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00894	CcSEcCtD
Risedronate—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00882	CcSEcCtD
Risedronate—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00876	CcSEcCtD
Risedronate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00876	CcSEcCtD
Risedronate—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00854	CcSEcCtD
Risedronate—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00843	CcSEcCtD
Risedronate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0084	CcSEcCtD
Risedronate—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00786	CcSEcCtD
Risedronate—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00781	CcSEcCtD
Risedronate—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00781	CcSEcCtD
Risedronate—Depression—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00779	CcSEcCtD
Risedronate—PTGS2—embryo—amyotrophic lateral sclerosis	0.00173	0.0283	CbGeAlD
Risedronate—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0076	CcSEcCtD
Risedronate—FDPS—brain—amyotrophic lateral sclerosis	0.00166	0.0271	CbGeAlD
Risedronate—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00739	CcSEcCtD
Risedronate—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00733	CcSEcCtD
Risedronate—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00705	CcSEcCtD
Risedronate—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00703	CcSEcCtD
Risedronate—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00701	CcSEcCtD
Risedronate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00696	CcSEcCtD
Risedronate—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00693	CcSEcCtD
Risedronate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00691	CcSEcCtD
Risedronate—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00689	CcSEcCtD
Risedronate—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00688	CcSEcCtD
Risedronate—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00656	CcSEcCtD
Risedronate—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00651	CcSEcCtD
Risedronate—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00636	CcSEcCtD
Risedronate—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00634	CcSEcCtD
Risedronate—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00632	CcSEcCtD
Risedronate—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00627	CcSEcCtD
Risedronate—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00615	CcSEcCtD
Risedronate—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00611	CcSEcCtD
Risedronate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00602	CcSEcCtD
Risedronate—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00591	CcSEcCtD
Risedronate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00587	CcSEcCtD
Risedronate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00564	CcSEcCtD
Risedronate—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00558	CcSEcCtD
Risedronate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00549	CcSEcCtD
Risedronate—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00548	CcSEcCtD
Risedronate—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00537	CcSEcCtD
Risedronate—Cough—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00533	CcSEcCtD
Risedronate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00527	CcSEcCtD
Risedronate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0052	CcSEcCtD
Risedronate—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0052	CcSEcCtD
Risedronate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0052	CcSEcCtD
Risedronate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00518	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00516	CcSEcCtD
Risedronate—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00508	CcSEcCtD
Risedronate—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.00111	0.0181	CbGeAlD
Risedronate—Infection—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00495	CcSEcCtD
Risedronate—Shock—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0049	CcSEcCtD
Risedronate—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00489	CcSEcCtD
Risedronate—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00484	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00454	CcSEcCtD
Risedronate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.001	0.00451	CcSEcCtD
Risedronate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000998	0.00447	CcSEcCtD
Risedronate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000991	0.00444	CcSEcCtD
Risedronate—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000987	0.0162	CbGeAlD
Risedronate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000978	0.00439	CcSEcCtD
Risedronate—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000959	0.0043	CcSEcCtD
Risedronate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000958	0.0043	CcSEcCtD
Risedronate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00095	0.00426	CcSEcCtD
Risedronate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00095	0.00426	CcSEcCtD
Risedronate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000909	0.00408	CcSEcCtD
Risedronate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00396	CcSEcCtD
Risedronate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00394	CcSEcCtD
Risedronate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00394	CcSEcCtD
Risedronate—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000832	0.0136	CbGeAlD
Risedronate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000819	0.00367	CcSEcCtD
Risedronate—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000801	0.0131	CbGeAlD
Risedronate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000797	0.00358	CcSEcCtD
Risedronate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000786	0.00353	CcSEcCtD
Risedronate—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000783	0.0128	CbGeAlD
Risedronate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00341	CcSEcCtD
Risedronate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000735	0.0033	CcSEcCtD
Risedronate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000706	0.00317	CcSEcCtD
Risedronate—Rash—Riluzole—amyotrophic lateral sclerosis	0.000701	0.00314	CcSEcCtD
Risedronate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0007	0.00314	CcSEcCtD
Risedronate—Headache—Riluzole—amyotrophic lateral sclerosis	0.000696	0.00312	CcSEcCtD
Risedronate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00296	CcSEcCtD
Risedronate—PTGS2—brain—amyotrophic lateral sclerosis	0.000636	0.0104	CbGeAlD
